Directory Category: Logistics
Samsung Bioepis Begins Commercialization of BYOOVIZ, Biosimilar to Lucentis (Ranibizumab), in Europe
Posted by James Spargo | Jan 2, 2026
Samsung Bioepis completes full transfer of commercial rights from Biogen back to Samsung Bioepis for BYOOVIZ BYOOVIZ becomes the fourth biosimilar directly commercialized by Samsung Bioepis in Europe, following EPYSQLI...
Read MoreMindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
Posted by James Spargo | Dec 23, 2025
23 December 2025 — Geneva, Switzerland — MindMaze Therapeutics Holding SA, a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases, today outlined the evolution of...
Read MoreInfant Bacterial Therapeutics AB secures partnership with Recipharm Advanced Bio for commercial production of drug substance
Posted by James Spargo | Dec 1, 2025
IBP-9414 targets mortality and gastrointestinal injury in premature infants With Breakthrough Therapy designation for gastro-intestinal mortality and Rare Paediatric Disease designations, IBP-9414 is on an accelerated path to...
Read More